Urology Lasers Market Size & Share 2023 to 2032
Market Size by Type (Holmium Laser System, Diode Laser System, Thulium Laser System), by Application (Benign Prostatic Hyperplasia {BPH}, Urolithiasis, Non-muscle-invasive Bladder Cancer {NMIBC}) by End Use– Global Forecast.
Download Free PDF

Urology Lasers Market Size
Urology Lasers Market size was valued at USD 1.2 billion in 2022 and is estimated to account for USD 2 billion by 2032. Urology lasers are advanced medical devices that utilize focused laser beams to diagnose and treat numerous conditions associated with the urinary tract.
Urology Lasers Market Key Takeaways
Market Size & Growth
Key Market Drivers
Challenges
These lasers offer precision and minimal tissue damage during endoscopy, enabling visualization and treatment of kidney stones, bladder tumors, and urethral strictures. Also, these systems are particularly effective in breaking down kidney stones through lithotripsy, fragmenting them into smaller pieces for easy removal. Urology lasers are also used for tissue ablation, coagulation, and vaporization, aiding in the removal of abnormal tissue growths, and treating benign prostatic hyperplasia (BPH) for improved urinary flow. Moreover, urology lasers offer several benefits including reduced bleeding, shorter recovery period, and minimal post-operative complications will boost customer preference thereby, accelerating product demand.
The global burden of chronic diseases including diabetes poses a significant risk factor for various urological complications such as diabetic nephropathy, diabetic cystopathy, urinary tract infections (UTIs), urological stones, erectile dysfunction, and urethral strictures lead to increasing urological procedures. For instance, according to the International Diabetes Federation (IDF) Diabetes Atlas report, in 2021, more than 10.5% of the adult population aged 20-79 years have diabetes and almost half of them are unaware of their condition. Additionally, the International Diabetes Federation (IDF) projected that approximately 783 million adults, or 1 in 8 individuals, will be living with diabetes by 2045.
COVID-19 Impact
The COVID-19 pandemic had a negative impact on the urology lasers market. During the early stages of the pandemic, healthcare systems worldwide faced challenges due to overwhelmed hospitals, diverted resources, and restrictions on elective procedures. Non-urgent and elective surgeries, including many urology laser procedures, were postponed, or cancelled to prioritize COVID-19 patients and conserve medical resources. As, hospitals and healthcare facilities adapted to the new challenges, implementing safety measures, and creating separate treatment zones. Telemedicine and remote patient monitoring gained prominence, allowing for continued management of urological conditions. As vaccination efforts increased and COVID-19 cases declined, the resumption of elective procedures addressed the pent-up demand for urology laser treatments.
Urology Lasers Market Trends
Technological advancements have led to the development of more sophisticated and precise medical laser systems, enabling healthcare professionals to perform urological procedures with improved accuracy and efficiency. For instance, Boston Scientific recently announced the U.S. FDA clearance for the LithoVue single-use digital flexible ureteroscope. This innovative device provides high-resolution digital images and navigation capabilities for better precision, speed, and cost-effectiveness. Such product launches with advanced technologies offered market expansion capabilities to the firm. Additionally, the rising preference for minimally invasive treatments among patients will impel the demand for urology lasers, as they offer reduced post-operative discomfort, shorter recovery times, and improved patient outcomes compared to traditional surgical methods.
Urology Lasers Market Analysis
The urology lasers market by type is categorized into holmium laser system, diode laser system, thulium laser system, and others. The holmium laser system segment garnered USD 411.5 million revenue size in the year 2022. These lasers cater a wide range of applications in treating kidney stones, bladder tumors, urethral strictures, and benign prostatic hyperplasia (BPH). Holmium lasers are particularly effective in fragmenting kidney stones, reducing patient discomfort, and minimizing the need for invasive procedures thereby, surging patient preference.
For instance, the Lumenis Pulse 120H holmium laser system integrated with MOSES technology from Boston Scientific Corporation represents a groundbreaking and patent-protected pulse delivery innovation. This advanced technology significantly enhances energy transmission, leading to highly efficient lithotripsy treatments compared to conventional holmium pulse systems. With ongoing technological advancements, these lasers offer enhanced efficiency and control during procedures.
On the basis of application, the urology lasers market is segmented as benign prostatic hyperplasia (BPH), urolithiasis, non-muscle-invasive bladder cancer (NMIBC), and others. The BPH segment accounted for over 38% market share in the year 2022. Benign prostatic hyperplasia is a prevalent condition affecting aging males. For instance, as per the National Institutes of Health, the prevalence of BPH experiences a notable increase after the age of 40, with a range of 8% to 60% observed among individuals by the time they reach 90 years of age, leading to increasing demand for effective treatment options.
Moreover, urology lasers offer a minimally invasive alternative to traditional surgeries, providing reduced discomfort and faster recovery. Their efficacy and precision in treating BPH by accurately ablating excess prostate tissue while preserving healthy tissue will contribute to improved patient outcomes and satisfaction. Growing awareness and acceptance of urology lasers in BPH treatment, along with technological advancements will spur the industry gains.
Based on end-use, the urology lasers market is segmented into hospitals, specialty clinics, and others. The hospitals segment is predicted to witness the highest progression at 5.5% CAGR by 2032. The growing healthcare infrastructure, integration of advanced technologies, and presence of skilled healthcare professionals for complex urological procedures. Furthermore, high patient volume among facilities and favorable reimbursement policies for urological procedures will drive the adoption rate of the business.
U.S. urology lasers market accounted for USD 414.5 million market size in 2022. Advanced healthcare infrastructure equipped with state-of-the-art hospitals and a strong presence of skilled professionals for urological treatments in the U.S. is poised to stimulate industry revenue expansion potential. The rising prevalence of urological conditions, combined with high healthcare spending and favorable reimbursement policies will foster the demand for urology lasers. Additionally, a well-informed population and growing awareness of the benefits of urology lasers.
Urology Lasers Market Share
Some of the eminent market participants operating in the urology lasers market include:
Urology Lasers Industry News:
Urology lasers devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:
Click here to Buy Section of this Report
By Type (USD Million & Units)
By Application (USD Million)
By End-use (USD Million)
The above information is provided for the following regions and countries:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →